Skin Cancer Evaluation & Treatment
Skin cancer is the most common type of cancer in the United States. It usually forms in skin that has been damaged by sunlight, but it can occur anywhere in the body. Your family genetics and past medical history may play major roles as well. Affecting an estimated 1 in 5 Americans in our lifetimes, skin cancer has the potential to impact us all.
There are two broad categories of skin cancer:
Non-Melanoma Skin Cancer
Squamous cell carcinoma and basal cell carcinomas may sometimes collectively be referred to as “non-melanoma skin cancers.” Detected early, these skin cancers usually respond to treatment and only rarely spread (“metastasize”) to other parts of the body.
Melanoma Skin Cancer
Melanoma is a typically more aggressive form of skin cancer. Left untreated, it is likely to invade nearby tissue and spread (“metastasize”). Melanoma causes the most deaths from skin cancer each year.
St. Luke’s Dermatology has board certified medical dermatologists and dermatological surgeons who have dedicated their professional lives to preventing and treating skin cancer. The focus of our comprehensive patient-centered Complex Cutaneous Oncology program is on the prevention and early detection of skin cancers. Our tools include our training and expertise, our access to cutting edge technologies, our high-impact clinical research, and our ability to educate our patients to live healthy skin lives.
If you have a skin cancer, our skin experts will partner with you to choose effective treatments and to develop strategies that help minimize your future risk for developing more.
Skin cancers that your St. Luke’s board certified dermatologist is likely to treat include:
- Angiosarcoma
- Basal cell carcinoma
- Cutaneous lymphoma
- Melanoma
- Merkel cell carcinoma
- Sebaceous carcinoma
- Squamous cell carcinoma